Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck earmarks €35m for Italian biologics site development

Merck earmarks €35m for Italian biologics site development Merck KgAa is set to invest 35m to expand its manufacturing site in the town of Modugno, Bari in Italy, to add a new production line for aseptic filing of biologics. ... Modugno is one of 15 manufacturing sites in operation by Merck and the facility

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio Merck KGaA and Pfizer's PD-L1 inhibitor Bavencio could be on the EU market from next month, after getting EMA approval as a treatment for the rare skin cancer Merkel ... The new product will be launched first in the UK and Germany, according to Merck,

Merck mulls sale of consumer health division

Merck mulls sale of consumer health division Merck KGaA says it is thinking about selling or partnering its consumer healthcare unit, narrowing its healthcare focus to biopharma development. ... We have maintained a solid position in attractive markets, and demonstrated a pattern of profitable

NICE expands Merck KGaA’s Erbitux reach

NICE expands Merck KGaA’s Erbitux reach Backs the medicines use for patients with SCCHN. After several attempts, Merck KgAa has finally persuaded the UK medicines cost-effectiveness watchdog to back its monoclonal antibody Erbitux (cetuximab), for use ... Byrne added: “Merck has worked

Ocrevus off to a flying start as Roche raises 2017 forecasts

Ocrevus off to a flying start as Roche raises 2017 forecasts The take-up of the drug has been buoyed by trials showing that the drug outperformed Merck KGaA's MS stalwart Rebif (interferon beta-1a) in two relapsing MS phase III

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...

Infographics